The Effects of Combination of Mimic miR-155-5p and Antagonist miR-324-5p Encapsulated Chitosan in Ovarian Cancer SKOV3.

Rahma B SuardiYsrafil YsrafilSalsabila L SesotyosariRonny MartienTirta WardanaIndwiani AstutiSofia Mubarika Haryana

Published in: Asian Pacific journal of cancer prevention : APJCP (2020)

This study successfully presented effects of combination of mimic miR-155-5p and antagonist miR-324-5p encapsulated chitosan which be considered as a potential therapy targets for ovarium cancer.

Keyphrases

drug delivery
papillary thyroid
hyaluronic acid
squamous cell carcinoma
stem cells
lymph node metastasis
young adults
chemotherapy induced